Compare distinct medicines and study contexts. Indications, formulation, adverse effects and clinician guidance must remain visible.
Separate studies, not a head-to-head trial. Source-checked conclusions do not validate older numerical estimates.
Source-checked conclusion: supported
Oral finasteride 1 mg is an established treatment for male-pattern hair loss. Benefit generally takes at least three months.
Not indicated for women; pregnancy exposure precautions apply. Sexual adverse effects are listed. Temple recession efficacy is not established.
Population: Adult men with androgenetic alopecia. Formulation: Finasteride 1 mg oral tablets.
AI-assisted source check dated 2026-09-30. Selected effect only.
Read Finasteride (Propecia) profile, recorded doses, risks and available costs
Source-checked conclusion: supported
Topical minoxidil 5% can help regrow hair on the crown in men with hereditary hair loss. Continued use is needed to maintain the benefit.
This source concerns topical use, not oral minoxidil. It does not establish efficacy for sudden hair loss or receding hairlines.
Population: Adult men with hereditary vertex hair loss. Formulation: Minoxidil 5% topical solution.
AI-assisted source check dated 2026-09-30. Selected effect only.
Read Minoxidil profile, recorded doses, risks and available costs
Keep your shortlist and create source-linked reports with Pro. Research and education, not medical advice.